Levy Wealth Management Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$1.71M Sell
11,665
-489
-4% -$72.7K 0.44% 27
2024
Q1
$1.91M Hold
12,154
0.53% 23
2023
Q4
$1.91M Buy
12,154
+19
+0.2% +$2.91K 0.53% 23
2023
Q3
$1.89M Buy
12,135
+23
+0.2% +$3.79K 0.59% 23
2023
Q2
$2M Sell
12,112
-289
-2% -$46.6K 0.59% 24
2023
Q1
$1.92M Buy
12,401
+412
+3% +$66.5K 0.59% 25
2022
Q4
$2.12M Sell
11,989
-47
-0.4% -$8.12K 0.71% 24
2022
Q3
$1.97M Buy
12,036
+1,311
+12% +$222K 0.85% 23
2022
Q2
$1.9M Sell
10,725
-62
-0.6% -$11K 0.87% 17
2022
Q1
$1.91M Buy
10,787
+481
+5% +$81.8K 0.79% 21
2021
Q4
$1.76M Buy
10,306
+16
+0.2% +$2.62K 0.8% 24
2021
Q3
$1.66M Buy
10,290
+15
+0.1% +$2.56K 0.91% 21
2021
Q2
$1.69M Buy
10,275
+517
+5% +$85.6K 0.97% 19
2021
Q1
$1.6M Buy
9,758
+123
+1% +$19.9K 1.05% 14
2020
Q4
$1.52M Buy
+9,635
New +$1.42M 1.08% 15

Other funds holding JNJ

Levy Wealth Management Group's JNJ Position: Q2 2024 in Review

Levy Wealth Management Group reduced its Johnson & Johnson (JNJ) stake by 4% in Q2 2024, selling an estimated $72.7K and leaving 11,665 shares worth $1.71M. The position accounts for 0.44% of the portfolio, ranked #27.

Levy Wealth Management Group first reported a position in JNJ in Q4 2020 and has held it in 15 quarters since. The position peaked at $2.12M in Q4 2022. 3,810 funds tracked by Wall St. Rank hold JNJ as of Q2 2024.

  • Levy Wealth Management Group held 11,665 shares of Johnson & Johnson worth $1.71M as of Q2 2024.
  • Levy Wealth Management Group sold 489 Johnson & Johnson shares in Q2 2024, an estimated $72.7K.
  • Johnson & Johnson made up 0.44% of Levy Wealth Management Group's portfolio in Q2 2024, its #27 holding.
  • Levy Wealth Management Group first reported a position in Johnson & Johnson in Q4 2020 and has held it in 15 quarters since.
  • Levy Wealth Management Group's Johnson & Johnson position peaked at $2.12M in Q4 2022.
  • 3,810 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2024.

Based on Levy Wealth Management Group's 13F filing for Q2 2024, filed 25 Jul 2024.